Use of chloroquine and clemizole compounds for treatment of inflammatory and cancerous conditions
First Claim
Patent Images
1. A method of treating a subject who has been diagnosed with liver cancer, comprising:
- administering to the subject an effective amount of clemizole, a deuterated analog of clemizole, or a clemizole metabolite; and
a chemotherapeutic agent.
1 Assignment
0 Petitions
Accused Products
Abstract
Disclosed herein are methods for use of R-chloroquine or clemizole or combinations of R-chloroquine and clemizole for the treatment of a subject in need thereof. Uses include methods of treating inflammatory′ conditions, treating liver cancer or reducing the risk of developing liver cancer in a subject. Uses also include methods of treating non-alcoholic steatohepatitis in a subject.
14 Citations
37 Claims
-
1. A method of treating a subject who has been diagnosed with liver cancer, comprising:
administering to the subject an effective amount of clemizole, a deuterated analog of clemizole, or a clemizole metabolite; and
a chemotherapeutic agent.- View Dependent Claims (2, 3, 4, 5, 6, 37)
-
7. A method of treating a subject who has been diagnosed with liver cancer, comprising:
-
administering to the subject an effective amount of clemizole, a deuterated analog of clemizole, or a clemizole metabolite, wherein the effective amount is 200-500 mg administered once daily, twice daily, or thrice daily. - View Dependent Claims (8, 9, 10, 11, 12, 13, 14, 15, 16, 17)
-
-
18. A method of treating a subject who has been diagnosed with liver cancer, comprising:
administering to the subject an effective amount of clemizole, a deuterated analog of clemizole, or a clemizole metabolite.
-
19. A method of preventing liver cancer development in a subject at risk for developing liver cancer, comprising:
-
administering to the subject an effective amount of clemizole, a deuterated analog of clemizole, or a clemizole metabolite, wherein the subject has been diagnosed with non-alcoholic steatohepatitis (NASH), non-alcoholic fatty liver disease (NAFLD), Hepatitis B infection, or cirrhosis of the liver. - View Dependent Claims (20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36)
-
Specification